LTT BIO-PHARMA CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 4134
 
 
 
C07D HETEROCYCLIC COMPOUNDS 3159

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9539248 Agent for ameliorating chronic obstructive pulmonary diseaseMay 22, 15Jan 10, 17[A61K, C07D]
9221786 2-fluorophenyl propionic acid derivativesDec 06, 12Dec 29, 15[C07D, C07C]
9161986 derivativeFeb 13, 12Oct 20, 15[A61K]
8916206 Nanoparticles containing water-soluble non-peptide low-molecular weight drugNov 29, 06Dec 23, 14[A61K]
8431614 Loxoprofen derivative and pharmaceutical preparation containing the sameFeb 18, 10Apr 30, 13[A61K, C07C]
5565444 Osteogenesis promoter and osteoporosis remedyNov 13, 95Oct 15, 96[A61K]
5362491 Modified biologically active protein compositionFeb 02, 94Nov 08, 94[A61K]
5310958 Lysolecithin derivativesFeb 07, 92May 10, 94[C07C]
5194670 Emulsion of lipid containing a prostaglandin analogueMar 24, 92Mar 16, 93[C07C]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0368,873 Optically Active Form of Mepenzolate, and Ameliorating Agent for Chronic Obstructive Pulmonary Disease Which Contains Same as Active IngredientAbandonedJun 16, 14Dec 22, 16[C07D]
2016/0317,437 EYE DROPS FOR TREATING DRY EYEAbandonedDec 25, 14Nov 03, 16[A61K]
2015/0038,719 Agent for Ameliorating Chronic Obstructive Pulmonary DiseaseAbandonedFeb 28, 13Feb 05, 15[A61K]
2014/0023,629 AMELIORATING AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedSep 20, 13Jan 23, 14[A61K]
2012/0034,202 AMELIORATING AGENT FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASEAbandonedMar 02, 10Feb 09, 12[A61K, C12N, A61P]
2011/0262,420 INHALANT COMPRISING MODIFIED SUPEROXIDE DISMUTASEAbandonedNov 09, 09Oct 27, 11[A61K, C12N, A61P]
2011/0262,548 NOVEL PROSTAGLANDIN E1 DERIVATIVE AND NANOPARTICLE HAVING THE SAME ENCAPSULATED THEREINAbandonedOct 16, 09Oct 27, 11[A61K, C07F, B82Y, A61P]
2010/0330,385 METHOD FOR TABLETING SURFACE TREATMENT OF TABLETING PUNCH OR DIE, PUNCH OR DIE SUBJECTED TO SURFACE TREATMENT BY THIS METHOD, AND TABLET FORMED BY USING THIS TABLETING PUNCH OR DIEAbandonedFeb 07, 09Dec 30, 10[C21D]
2010/0143,321 THERAPEUTIC COMPOSITION FOR INTERSTITUAL PNEUMONIAAbandonedDec 19, 07Jun 10, 10[A61K, A61P]
2010/0129,456 SUSTAINED-RELEASE NANOPARTICLE CONTAINING LOW-MOLECULAR-WEIGHT DRUG WITH NEGATIVELY CHARGED GROUPAbandonedApr 11, 08May 27, 10[A61K]
7642230 Zinc-containing sustained-release composition, its preparation, and method for producing the sameExpiredApr 01, 04Jan 05, 10[A61K]
2009/0314,824 METAL SURFACE TREATMENT METHODAbandonedNov 10, 07Dec 24, 09[B21D]
2008/0113,014 Method for Screening for Compounds Safe for Gastric MucosaAbandonedDec 15, 04May 15, 08[A61K, G01N]
2007/0258,926 Composition containing retinoic acid nanoparticles coated with inorganic salt of polyvalent metalAbandonedOct 15, 03Nov 08, 07[A61K]
2007/0196,532 Punch or die for tablettingAbandonedMay 15, 06Aug 23, 07[A01J]
2007/0077,286 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticleAbandonedOct 12, 04Apr 05, 07[A61K]
2006/0233,883 Intravenous nanoparticles for targeting drug delivery and sustained drug releaseAbandonedMar 11, 04Oct 19, 06[A61K]
2006/0093,670 Sustained-release composition process for producing the same and preparation thereofAbandonedJun 09, 03May 04, 06[A61K]
2006/0088,598 Intravenous composition, process for producing the same and preparation thereofAbandonedMay 27, 03Apr 27, 06[A61K]
6800607 Modified BDNFExpiredAug 29, 02Oct 05, 04[A61K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.